Dr Hanna drives a discussion regarding breast cancer treatments that have developed resistance to CDK 4/6 inhibitors. Kirollos S. Hanna, PharmD, BCPS, BCOP, FACCC: Let’s say a patient wasn’t compliant ...
The Maine Cancer Genomics Initiative: Implementing a Community Cancer Genomics Program Across an Entire Rural State We retrospectively analyzed a multi-institutional cohort of patients with ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. SAN ANTONIO — Longer duration of cyclin-dependent kinase ...
Nurse-Led Individualized Follow-Up Versus Regular Physician-Led Visits After Early Breast Cancer (MyHealth): A Phase III Randomized, Controlled Trial Cyclin-dependent kinase (CDK) 4/6 inhibitors (CDK4 ...
Kirollos S. Hanna, PharmD, BCPS, BCOP, FACCC, opens a panel discussion surrounding the treatment pathways for patients diagnosed with early breast cancer. A panel of medical experts explore the impact ...
CENTER CITY -- This week, we're focused on Beating the Odds Against Breast Cancer, with the word on new advances, and some people trying to make a difference. This afternoon, a look at 2 new drugs ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results